Advertisement

Acta Neuropathologica

, Volume 106, Issue 6, pp 518–526 | Cite as

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

  • Kazuhiro Imamura
  • Nozomi Hishikawa
  • Makoto Sawada
  • Toshiharu Nagatsu
  • Mari Yoshida
  • Yoshio Hashizume
Regular Paper

Abstract

There are numerous observations confirming that microglia expressing major histocompatibility complex (MHC) class II molecules are associated with the central nervous system (CNS) in aging and pathological conditions. In this study, we investigated the distribution of MHC class II-positive microglia in Parkinson's disease (PD) brains. The number of MHC class II-positive microglia in the substantia nigra (SN) and putamen increased as the neuronal degeneration of the SN proceeded. These cells were also ICAM-1 (CD54) and LFA-1 (CD11a) positive. The number of activated microglia not only in the SN and putamen but also in the hippocampus, transentorhinal cortex, cingulate cortex and temporal cortex in PD was significantly higher than that in the normal control. Most activated microglia persisted regardless of the presence or absence of Lewy bodies. They were frequently associated not only with α-synuclein-positive Lewy neurites, but also with TH-16-positive dopaminergic and WH-3-positive serotonergic neurites, as well as MAP-2- and SMI-32-positive neurites. These activated microglia were also positive for TNF-α and interleukin-6, which are known to have a neuroprotective function. We conclude that MHC class II-positive microglia are a sensitive index of neuropathological change and are actively associated with damaged neurons and neurites.

Keywords

Parkinson's disease Microglia MHC class II antigen ICAM-1 Cytokines 

References

  1. 1.
    Akiyama H, Kawamura T, Yamada T, Tooyama I, Ishii T, McGeer PL (1993) Expression of intercellular adhesion molecule (ICAM-1) by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol 85:628–634PubMedGoogle Scholar
  2. 2.
    Alexianu ME, Kozovska M, Appel SH (2001) Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282–1289Google Scholar
  3. 3.
    Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP (1995) Tumor necrosis factors α and β protect neurons against amyloid β-peptide toxicity: evidence for involvement of a kB-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92:9328–9332Google Scholar
  4. 4.
    Batchelor PE, Liberatore GT, Wong JYF, Porritt MJ, Frerichs F, Donnan GA, Howells DH (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19:1708–1716PubMedGoogle Scholar
  5. 5.
    Bevezovskaya O, Maysinger D, Fedoroff S (1995) The hemapoietic cytokine, colony stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int J Dev Neurosci 13:285–299CrossRefPubMedGoogle Scholar
  6. 6.
    Braak H, Braak E, Yilmazer D, Vos RAI, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88:493–500CrossRefPubMedGoogle Scholar
  7. 7.
    Brown H, Kozlowski R, Perry VH (1998) The importance of ion channels for macrophage and microglia activation in vitro. Glia 22:94–97CrossRefPubMedGoogle Scholar
  8. 8.
    Bruce-Keller AJ (1999) Microglial-neuronal interactins in synaptic damage and recovery. J Neurosci Res 58:191–201CrossRefPubMedGoogle Scholar
  9. 9.
    Cai TQ, Wright SD (1995) Energetics of leukocyte integrin activation. J Biol Chem 270:14358–14365CrossRefPubMedGoogle Scholar
  10. 10.
    Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD Jr, Bennett JP Jr (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1362:77–86CrossRefPubMedGoogle Scholar
  11. 11.
    Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149:2736–2741PubMedGoogle Scholar
  12. 12.
    Cheng B, Mattson M (1994) Tumor necrosis factors protect neurons against excitotoxic /metabolic insults and promote maintenance of calcium homeostasis. Neuron 12:139–153Google Scholar
  13. 13.
    Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosman CF (1991) Microglia in human disease with an emphasis on acquired immune deficiency syndrome. Lab Invest 64:135–156PubMedGoogle Scholar
  14. 14.
    Gai WP, Blessing WW, Blumbergs PC (1995) Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease. Brain 118:1447–1459PubMedGoogle Scholar
  15. 15.
    Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, Li X, Kirkpatrick JB (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119–137CrossRefPubMedGoogle Scholar
  16. 16.
    Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-prignot A, Turmel H, Srinivasan A, Ruberg M, Evan GL, Agid Y, Hirsch EC (2000) Caspase-3: a vulnerability factor and a final effector in the apoptotic cell death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97:2875–2880PubMedGoogle Scholar
  17. 17.
    Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21:2247–2255PubMedGoogle Scholar
  18. 18.
    Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292PubMedGoogle Scholar
  19. 19.
    Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, Hirsch EC (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72:355–363CrossRefPubMedGoogle Scholar
  20. 20.
    Imamura K, Ito M, Suzumura A, Asai J, Takahashi A (1990) Generation and characterization of monoclonal antibodies against rat microglia and ontogenic distribution of positive cells. Lab Invest 63:853–861PubMedGoogle Scholar
  21. 21.
    Isaksson J, Farooque M, Holtz A, Hillered L, Olsson Y (1999) Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats. J Neurotrauma 16:165–173PubMedGoogle Scholar
  22. 22.
    Iseki E, Kato M, Marui W, Ueda K, Kosaka K (2001) A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies. J Neurol Sci 185:129–134PubMedGoogle Scholar
  23. 23.
    Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia in and around senile (neuritic) plaques in Alzheimer brain. J Neuroimmunol 24:173–182PubMedGoogle Scholar
  24. 24.
    Jellinger KA (2000) Cell death mechanism in Parkinson's disease. J Neural Transm 107:1–29CrossRefPubMedGoogle Scholar
  25. 25.
    Kettenmann H, Hoppe D, Gottmann K, Bannati R, Kreutzberg G (1990) Cultured microglial cells have a distinct pattern of membrane channels different from peritoneal macrophages. J Neurosci Res 26:278–287PubMedGoogle Scholar
  26. 26.
    Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309–6316PubMedGoogle Scholar
  27. 27.
    Koutsilieri E, Scheller C, Grünblatt E, Nara K, Li J, Riederer P (2002) Free radicals in Parkinson's disease. J Neurol 249 (Suppl 2):II/1–II/5Google Scholar
  28. 28.
    Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312–318PubMedGoogle Scholar
  29. 29.
    Lazarov-Spiegler O, Soloman AS, Zeev-Brann AB, Hirschberg DL, Lavie V, Schwartz M (1996) Transplantation of activated macrophages overcomes central nervous system regrowth failure. FASEB J 10:1296–1302PubMedGoogle Scholar
  30. 30.
    Liu B, Du L, Hong JS (2000) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607–617Google Scholar
  31. 31.
    Mackenzie IRA (2000)Activated microglia in dementia with Lewy bodies. Neurology 55:132–134PubMedGoogle Scholar
  32. 32.
    Mattiace LA, Davies P, Dickson DW (1990) Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 136:1101–1114Google Scholar
  33. 33.
    McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79:195–200CrossRefPubMedGoogle Scholar
  34. 34.
    McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Expression of HLA-DR and interleukin-2 receptors on reactive microglia in senile dementia of Alzheimer type. J Neuroimmunol 16:122CrossRefGoogle Scholar
  35. 35.
    McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38:1285–1291PubMedGoogle Scholar
  36. 36.
    McGeer PL, Itagaki S, Tago H, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76:550–557PubMedGoogle Scholar
  37. 37.
    McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7:84–92PubMedGoogle Scholar
  38. 38.
    McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM (2001) Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol 169:219–230CrossRefPubMedGoogle Scholar
  39. 39.
    McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon, DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMedGoogle Scholar
  40. 40.
    Mirza B, Hadberg H, Thomsen P, Moos T (2000) The absence of reactive astrocytosis is indicative of a unique inflammation process in Parkinson's disease. Neuroscience 95:425–432CrossRefPubMedGoogle Scholar
  41. 41.
    Moller JC, Klein MA, Haas S, Jones LL, Kreutzberg GW, Raivich G (1996) Regulation of thrombospondin in the regenerating mouse facial nucleus. Glia 17:121–132CrossRefPubMedGoogle Scholar
  42. 42.
    Nagata K, Nakajima K, Kohsaka K (1993) Plasminogen promotes the development of rat mesencephalic dopaminergic neurons in vitro. Dev Brain Res 75:31–37CrossRefGoogle Scholar
  43. 43.
    Nagatsu T, Mogi M, Ichinose H, Togari A, Riederor P (1999) Cytokines in Parkinson's disease. Neuro Sci News 2:88–90Google Scholar
  44. 44.
    Perry VH (1998) A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J Neuroimmunol 90:113–121CrossRefGoogle Scholar
  45. 45.
    Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15:313–326CrossRefPubMedGoogle Scholar
  46. 46.
    Prewitt LM, Niesmann IR, Kane CJM, Houle JD (1997) Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol 148:433–443CrossRefPubMedGoogle Scholar
  47. 47.
    Rabchevsky AG, Streit WJ (1997) Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47:34–48CrossRefPubMedGoogle Scholar
  48. 48.
    Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 9:339–349PubMedGoogle Scholar
  49. 49.
    Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL (1989) A4 protein in AD: primary and secondary cellular events in extracellular amyloid deposits. J Neuropathol Exp Neurol 48:647–663Google Scholar
  50. 50.
    Sawada M, Suzumura A, Marunouchi T (1995) Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13:253–264CrossRefPubMedGoogle Scholar
  51. 51.
    Styren SD, Civin WH, Rogers J (1990) Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 110:93–104PubMedGoogle Scholar
  52. 52.
    Sudo S, Tanaka J, Toku K, Desaki J, Matsuda S, Arai T, Sakanaka M, Maeda N (1998) Neurons induce the activation of microglial cells in vitro. Exp Neurol 154:499–510CrossRefPubMedGoogle Scholar
  53. 53.
    Toku K, Tanaka J, Yano H, Desaki J, Zhang B, Yang L, Ishihara K, Sakanaka M, Maeda N (1998) Microglial cells prevent nitric oxide-induced neuronal apoptosis in vitro. J Neurosci Res 53:415–425CrossRefPubMedGoogle Scholar
  54. 54.
    Upender MB, Naegele JR (1999) Activation of microglia during developmentally regulated cell death in the cerebral cortex. Rev Neurosci 21:491–505CrossRefGoogle Scholar
  55. 55.
    Werner A, Kloss CUA, Walter J, Kreutzberg GW, Raivich G (1998) Intercellular adhesion molecule-1 (ICAM-1) in the mouse facial motor nucleus after axonal injury and during regeneration. J Neurocytol 27:219–232Google Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Kazuhiro Imamura
    • 1
  • Nozomi Hishikawa
    • 2
  • Makoto Sawada
    • 3
  • Toshiharu Nagatsu
    • 3
  • Mari Yoshida
    • 4
  • Yoshio Hashizume
    • 4
  1. 1.Department of NeurologyOkazaki City HospitalAichiJapan
  2. 2.Department of NeurologyNagoya University School of MedicineAichiJapan
  3. 3.Institute for Comprehensive Medical ScienceFujita Health University, Japan Science and Technology CorporationAichiJapan
  4. 4.Department of Neuropathology, Institute for Medical Science of AgingAichi Medical UniversityAichiJapan

Personalised recommendations